2-Phenyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95.0%, 250mg

Ethane-1,1,2,2-tetracarboxylic acid tetramethylester, 98.0%, 1g

2,2-Dimethylvaleric Acid>98.0%(GC)(T)25mL

Methyl 2-(4-(1-hydroxy-4-(4-(hydroxydiphenylmethyl)piperidin-1-yl)butyl)phenyl)-2-methylpropanoate, 97%, 250mg

ETHYL 2-(1-HYDROXYCYCLOBUTYL)ACETATE, 95.0%, 5g

5-Chloro-2,3-diphenylpyrazine, 95.0%, 5g

2-(4-Chlorophenyl)ethanol, 95.0%, 500g

(R)-(+)-2-Amino-3-methyl-1,1-diphenyl-1-butanol>98.0%(HPLC)(T)1g

1H-Benzimidazole, 6-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfonyl]-, 98%, 500mg

Three-necked round-bottom flasks side necks, bevelled, 500 ml, 29/32, 19/26, 1 Piece

(S)-4-Bromo-2-((tert-butoxycarbonyl)amino)pent-4-enoic acid, 95.0%, 250mg

5-BROMO-3-(1-METHYLPIPERIDIN-4-YL)-1H-INDOLE, 97.0%, 250mg

3-Methoxy-2-methylaniline, 97.0%, 100g